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Incidence of type 1 diabetes (T1D) is on the rise and yet, despite decades of
research, the exact ethology of the disease still remains a mystery. The autoimmune
reaction, which ultimately leads to the destruction of pancreatic beta cells, causing
insulin deﬁciency and T1D, is a result of genetic susceptibility and environmental
factors. Precisely, what are these environmental factors? Current popular opinion
implies these pathogens, such as viruses, especially human enteroviruses, are a
triggering factor. On the other hand, the hygiene hypotheses states in which the increase
of autoimmune diseases, such as T1D, can, in fact, be explained by the decrease of
infections, and infectious agents, more like viruses, actually serve as a defense
mechanism, therefore, protect us from developing certain autoimmune diseases. Addi-
tionally, the relationship between the gut microbiota and autoimmune diseases is
currently gaining increased interest including relative research now demonstrating how
the guts immune system plays a crucial role in the development of autoimmune diseases.
This literature review aims to evaluate these three popular suspects: Viral infections,
hygiene and gut microbiota, in relation to their potential triggering effect on T1D and
their close relationship to one another.
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Introduction
Type 1 diabetes (T1D) is a disease characterized by an immune-mediated
destruction of pancreatic β cells [1]. The disease is on the rise, with an overall
annual increase estimated at approximately 3% [2]. Genetics is a well-known
contributor to the disease [1], yet, genetics alone cannot explain this rapid increase
in recent incidences. The disease does not conform to any known Mendelian
pattern of inheritance [3], and studies show in which fewer than 10% of people
with human leukocyte antigen (HLA)-determined susceptibility to T1D develop
the disease and monozygotic twins have less than 40% concordance of developing
T1D [4].
A model originally posted in 1986, and modiﬁed throughout the years [1],
suggests individuals are born with various degrees of genetic predisposition, and
an environmental trigger induces β cell autoimmunity.
What speciﬁcally is this environmental trigger is the primary focus of this
literature review includes the following popular theories: the hygiene hypothesis,
gut microbiota and viral infection.
The Hygiene Hypothesis
This theory states in which the increase in frequency of T1D throughout
several countries can be explained by the decline of infections [5]. In recent
years, attention has been focused on the possibility in which lifestyle changes
plays a major factor in the rise of T1D and other autoimmune diseases. Several
lifestyle changes have developed in the last 20 years, and one is the decline
in infectious disease, as a result of increased hygiene, health and medical
conditions [6].
Geographical data and epidemiology
The difference of incidence rate between countries plays a major role in this
theory. As Figure 1 demonstrates, throughout Europe, there is a north–south
gradient of T1D, exhibiting higher frequency in the Scandinavian countries, and,
less so in Southern Europe, and a low presence throughout Africa. Similarly,
higher incidences are seen in North America when compared with South America.
The geographical map of published incidence rates for childhood T1D is the
mirror image of that for infectious disease distribution, as seen in Figure 2.
Tuberculosis and childhood diarrhea are more frequent in the southern countries
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compared with those of the north [5]. In the case of tuberculosis, a negative
correlation between the frequency of the disease and T1D has been shown [5].
However, differences between small geographical areas have also been found.
For example inexplicably, the frequency of T1D is threefold higher in Finland when
compared with its geographic neighbor, Russian Karelia [5], although they have the
same ethnic background and are separated only by a few dozen kilometers.
Among the several factors implicating an environmental factor, current
migration studies exist. Families emigrating from countries with a low T1D
incidence to a high T1D incidence country experienced an increase in frequency
of the disease in its ﬁrst-generation migrants, and vice versa. This has been observed
in several migrant populations, in particular, Pakistanis now residing in England [5].
One of the more remarkable arguments supporting the hygiene hypothesis is
the reverse trend observed between infectious disease incidence and the incidence
of autoimmune diseases [5]. In addition, relative and speciﬁc evidence also exists.
There is a negative correlation between hygiene condition and T1D, in Northern
Ireland, showing that the areas with lowest T1D incidences are in areas with the
poorest hygiene conditions [6].
Figure 1. Estimated new cases of type 1 diabetes (<15 years) per 100,000 children per year, 2015.
IDF Diabetes Atlas (2015) published by the International Diabetes Federation was used to produce
the estimates
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It was also shown in which the T1D incidence rate was higher in children
who have had the lowest level of infectious exposure [6].
Animal models
Experimental models offer the superb advantage in allowing deliberate
interventions. Non-obese diabetic (NOD) mice spontaneously developed T1D at
the age of 2–3 months, and the incidence of the disease and the acceleration of the
onset is largely dependent in the way the animals were taken care of, particularly
their sanitary conditions [5]. When the sanitary conditions were poor, the fre-
quency of the disease has decreased, and incidences increased again by decon-
tamination through C-section and raising newborns in isolation [6]. Inversely, it is
possible to prevent the onset of diabetes by deliberately infecting mice, which was
previously raised in a clean environment with some various infective agents, such
as complete Freund’s adjuvant, mouse hepatitis viruses, and Schistosoma mansoni
soluble egg antigens [5]. Biobreeding (BB) rats in a germ-free facility also have
increased diabetes frequency, and prevention could be achieved by various
infections [6].
Figure 2. Estimated TB incidence rates, 2015. Global tuberculosis reports (2016) published by
WHO was used to produce the estimates
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Human therapeutic trials
Currently, there is no known direct evidence showing that the suppression of
infections causes a rise in T1D, yet the available evidence from other studies can
prove useful.
Helminthiases treatment performed in countries of high incidence of these
parasites demonstrates the disappearance of the parasite and is linked to an
increase in atopic disease [6]. Similar observations have been made in Southern
Africa, with respect to vaccination against Streptococcus pneumonia [6]. Clearly,
this indicates how a decrease of infection caused an increase of certain diseases
and inversely, the question may be asked as to whether an increase of infections
can suppress the onset of certain autoimmune or allergic disease in humans [6].
Gut Microbiota
The human intestinal microbiome is a complex, symbiotic ecological
community, which inﬂuences human health and development, including the
development, function, and maintenance of the human immune system [7]. This
fact is precisely why the relationship between the gut microbiota and autoimmune
diseases has gained an immense amount of interest within the past decade,
including its relationship to T1D. The microbiota hypothesis, in contrast to the
hygiene hypothesis, focuses more on our ancestral microorganisms rather than
cleanliness and postulates the lack of symbiotic microorganisms as being respon-
sible for the disease [8].
The microbiome consists of hundreds of trillions of microorganisms,
including more than 1014 bacteria belonging to 1,000 species, Archaea, bacterio-
phage particles, viruses, eukaryotes, and fungi [9, 10].
The microbiota is, at birth, characterized by instability and low diversity.
Its composition is in fact dynamic and inﬂuenced by several factors, such as birth
delivery mode, breastfeeding and food introduction, geography, immunological
status, and the use of antibiotics and hygiene conditions. The early childhood
represents the period in which microbiota composition becomes more complex
and long-term colonization by most of bacteria is established [9]. For example,
it has been shown that the risk and onset of T1D in childhood is higher in children
delivered by C-section [11].
External factors inﬂuence the function and composition of the microbiota
and, in particular, the diet [11]. An example of this can be presented in the study of
twins, revealing how obese individuals have reduced the diversity of intestinal
microbiome when compared with their lean twin [11].
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Although many phyla are represented, and signiﬁcant variability exists
between individuals, recently, molecular techniques identiﬁed four major microbial
phyla that represent over 90% of the gut microbiota: Firmicutes, Bacteroides,
Protobacteria, and Actinobacteria [12]. Most of the commensal bacteria found in
human fecal ﬂora are represented by two main groups of Firmicutes, subdivided in
Clostridium coccoides (Clostridium cluster XIVa) and Clostridium leptum
(Clostridium cluster IV), and the group of Cytophaga–Flavobacterium–Bacteroides
[12]. The gut microbiota plays an important role being mainly involved in the
development and growth of immune system and in the regulation of several
fundamental metabolic pathways. For instance, Clostridium clusters IV and XIVa
have an important role in immune gut homeostasis modulating the expression of
Foxp3 in CD4+ T cells by production of short-chain fatty acid (SCFA) [12].
Intestinal microbiota and autoimmunity
The intestinal mucosa is a common entry site for pathogens and contains a
signiﬁcant amount of cells of the immune system. An intact mucosa provides the
ﬁrst line of defense against pathogens, and the research continues to deﬁne the
vital role the intestinal microbiota plays in protecting the mucosa from invading
pathogens and inﬂuencing the development and maintenance of both the systemic
and innate immune systems [11].
Epidemiological data reveal a high prevalence of autoimmune diseases in
developed countries compared with developing countries, creating the original
basis for the “hygiene hypothesis.” This hypothesis has been further developed to
include concept in which altered intestinal microbiota may be one of several
predisposing factors for the development of autoimmunity, as demonstrated in
Figure 3 [11].
In addition to the knowledge in which intestinal microbiota contributes to the
development and maintenance of the immune system, several studies demonstrate the
relationship between autoimmune diseases and the intestinal ﬂora. Inﬂammatory
bowel diseases (IBDs) are autoimmune diseases of the intestinal tract, and although
the exact etiology of IBD is as of yet unclear, it likely involves environmental, genetic,
and immune factors [11]. The role of the microbiome in IBD development is
becoming increasingly deﬁned, and several studies illustrate a relationship. Animal
studies have revealed that the severity of experimentally induced intestinal inﬂam-
mation can be modulated by introduction of anaerobic bacteria [11]. Metagenomic
evaluation of fecal samples taken from patients afﬂicted with Crohn’s disease revealed
a reduced diversity of the Firmicutes phyla compared with healthy controls [11].
Patients suffering from Crohn’s disease and ulcerative colitis have a reduced amount
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of bacteria in the Firmicutes and Bacteroidetes phyla, and there is an altered intestinal
microbiome in individuals with Crohn’s disease compared with their monozygotic
twin [11]. Alterations in intestinal ﬂora have been hypothesized to contribute in the
development of several other autoimmune diseases, including celiac disease, allergy,
multiple sclerosis, rheumatoid arthritis, and ankylosing spondylitis [11]. In addition,
an increasing amount of experimental data from humans and animal models has
supported the role played by imbalanced gut microbiota and T1D [9].
Considering this evidence, it is only natural to assume that a relationship
exists between the gut microbiota and T1D.
Animal models
Flora variation. Peyer’s patches, splenic germinal centers, mesenteric lymph
nodes, plasma cells, and CD4+ T cells of germ-free mice are smaller and/or
fewer when compared with mice raised in a normal environment [11]. In germ-free
animals, reintroduction of normal gut ﬂora can normalize the size and cellularity of
lymphoid structures and increase antibody production. It was shown that the
introduction of a single organism, segmented ﬁlamentous bacterium, was sufﬁ-
cient to stimulate production of IL-17 producing CD4+ T cells [11].
Studies using NOD mice demonstrate chronic viral infections, mycobacte-
rial infections, and stimulus with bacterial antigens decreased the development of
Figure 3. Environmental factors that may directly or indirectly alter the intestinal microbiome and
therefore affect the risk of autoimmune diabetes
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T1D [11]. However, female NOD mice, affected by Bacillus cereus, delayed the
onset of T1D [11], suggesting that the incidence of T1D in NOD mice is
modulated by restricted ﬂora, and not germ-free conditions.
Using ﬂuorescent in situ hybridization to target 16S rRNA of Bacteroides,
Clostridium, and Lactobacillus species in fecal samples of biobreeding diabetes-
prone (BB-DP) rats, it has been demonstrated that the Bacteriodes species were
more prominent in those rats which developed diabetes, and further experiments
have revealed that there is a higher proportion of Lactobacillus and Biﬁdobacter-
ium genera in biobreeding diabetes-resistant rats compared with BB-DP rats,
while BB-DP rats were again found to have a higher amount of the Bacteroides
species [11].
Flora modulation. Gut microbiota hydrolyze and ferment the dietary polysac-
charides to generate monosaccharides and SCFAs that can be absorbed and
utilized by the host for energy. SCFAs, such as acetate, propionate, and butyrate,
contribute approximately 5%–10% to human energy resources [10]. These SCFAs
have been well characterized as playing a role in gut immune homeostasis. Mice
that take acetate through drinking water display suppressed dextran sulfate
sodium-induced colitis, inﬂammatory arthritis, and asthma in a Gpr43-dependent
manner [13]. Additionally, NOD mice that consumed acid water lead to a decrease
in Firmicutes and an increase in Bacteroidetes, which in turn was associated with
an increased onset of diabetes in NOD mice [12].
The initial evidence suggesting a role of nutrition in T1D was accomplished
using NOD mice exposed to a diet consisting of wheat ﬂour or hydrolyzed casein,
revealing a signiﬁcant lower rate of incidence of diabetes in mice receiving the
hydrolyzed diet. Further studies completely prevented the diabetes by providing
antibiotics and hydrolyzed diet to BB-DP rats [11].
Several other studies have been achieved to effectively and precisely
pinpoint the components and mechanisms of diet upon T1D. NOD mice lacking
exposure to dietary gluten develop diabetes at a signiﬁcant lower rate when
compared with mice on a standard diet [11]. Investigation into the mechanisms of
insulitis development and T1D in animals on a gliadin diet suggests these proteins
increase small intestine inﬂammation and intestinal permeability [14]. Further-
more, BB-DP rats have a higher proportion of Th1 cells in the mesenteric lymph
nodes upon exposure to wheat [11]. Notably, exposure to gliadin also suppresses
Treg cell production in NOD mice, which is another potential mechanism by
which dietary exposure may enhance T1D risk [11].
Another study, which performed toward examining the effect of a gluten-
free diet versus standard diet on bacterial composition in NOD mice, demonstrate
how diabetes developed in 47% of the standard-diet mice, compared with only 5%
in the gluten-free diet mice, and examination of the intestinal bacteria revealed a
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signiﬁcantly lower prevalence of aerobic, microaerophilic, and anaerobic bacteria
in mice on the gluten-free diet [11]. Much of the difference in bacterial composi-
tion was directly attributable to Gram-positive bacteria [11]. An in vitro study
highlighted how intestinal epithelial cells in culture exposed to gliadin-derived
peptides produced inﬂammatory cytokines, and this process was downregulated
when these cells were inoculated with the intestinal bacteria Biﬁdobacteria,
suggesting a mechanism by which intestinal bacteria can protect intestinal
integrity [11].
An interesting subject is if manipulation of the gut microbiota can play a
role in modulating the onset of T1D. To date, this has only been tested on
animal models, where the gut microbiota from a MyD88-deﬁcient NOD mice
(which were protected from T1D development) were transplanted in NOD
mice. A reduced onset of insulitis and a signiﬁcant delay of diabetes were
observed [12]. Speciﬁc probiotic strains of Lactococcus lactis genetically
modiﬁed to secrete the whole proinsulin autoantigen along with the immu-
nomodulator IL-10 was able to revert diabetes in NOD mice [12]. It has also
been shown that gender can play an important role in the development of T1D.
Female NOD mice are signiﬁcantly more susceptible to T1D than males.
Transfer of male microbiota to female NOD prior to disease onset protected
against pancreatic islet inﬂammation, autoantibody production, and the de-
velopment of the disease [12]. Another dietary mean by which gut bacteria
could be altered includes the ingestion of probiotics – “live microorganisms
that, when administered in adequate amounts, confer a health beneﬁt on the
host” [8]. Administration of the probiotic mixture VSL#3 containing
Streptococcus thermophiles, Biﬁdobacterium spp., and Lactobacillus spp.
was shown to prevent diabetes development in NOD mice [12]. Additionally,
Lactobacillus spp. was investigated in the prevention of T1D. Lactobacillus
johnsonii or Lactobacillus reuteri isolated from diabetes-resistant rat was
administered to BB-DP rats. L. johnsonii, but not L. reuteri, post-weaned the
onset of T1D [12].
Another way to manipulate and alter the gut microbiota is through anti-
biotics. Antibiotics have been used in modern societies to treat infections caused
by pathogens. As a consequence, the intestinal microbiome is affected by
antibiotic usage [8]. Although most data exist from animal models, antibiotic
use in mice and in humans induces the proliferation of pathogens in the intestine,
including Clostridium difﬁcile and Salmonella enterica [9]. Animal studies
demonstrate that the antibiotic-induced modulation of the gut microbiome affects
autoimmune diseases [8]. It has been shown that the oral antibiotic treatment of
pregnant mice could alter the gut microbiota composition in the offspring, but
there was no signiﬁcant change in the development of T1D [8]. Other studies,
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however, demonstrate that the modulation of the gut microbiota composition by
antibiotic treatment affects diabetes development in BB-DP rats and NOD mice.
Long-term vancomycin treatment depleted many major bacteria genera, except for
the species Akkermansia muciniphila, which became dominant and inhibited
diabetes development in NOD mice [8]. However, it is noteworthy that diabetes
development was critically affected by the type of antibiotic used as well as the
timing of treatment [8]. Another study suggests that targeting Gram-negative
bacteria protects NOD mice from diabetes development, whereas depleting
Gram-positive bacteria accelerated diabetes in NOD mice. This study also
indicates that the most effective time of treatment is early in life, which is
consistent with other studies of early-life microbiota disruption and other meta-
bolic disorders, such as obesity [8].
Human studies
Flora variation. A study [11] attempting to deﬁne the difference in bacterial ﬂora
between children who develop T1D and healthy controls revealed that the
intestinal microbiota in children who developed T1D had a higher proportion
of Bacteroidetes phyla (Gram-negative) and lower proportion of Firmicutes phyla
(Gram-positive), whereas control patients exhibited a decrease of Bacteroidetes
phyla and an increase of Firmicutes phyla. Within the Bacteroidetes phyla, the
Bacteroides ovatus species represented 24% of the total increase.
A Spanish cohort study showed that people with T1D had an increased
amount of Clostridium, Bacteroides, and Vellionella and a reduced amount of
Biﬁdobacterium and Lactobacillus compared with controls. Interestingly, the
latter two organisms have been regarded as beneﬁcial and are used as probiotic
candidates [15].
Additionally, it is shown that adequate butyrate production levels are
essential for gut integrity [12]. The butyrate-producing bacteria have anti-
inﬂammatory effect both in vivo and in vitro studies [12]. This is interesting
since studies show that butyrate-producing bacteria (Eubacterium, Fusibacterium,
Anaerostipes, Roseburia, Subdoligranulum, and Faecalibacterium) are more
abundant in controls compared with T1D cases, whereas lactate producers
(Lactobacillus, Lactococcus, Biﬁdobacterium, and Streptococcus) were more
common in T1D cases [12]. Additional studies showed that streptococci and
Bacteroidetes were more represented in diabetic children, while the combined
abundance of Clostridium clusters IV and XIVa was higher in healthy controls
[12]. These human studies support the notion that alteration in gut microbiota is
related to β-cell autoimmunity and T1D.
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Flora modulation. Diet modulates the gut microbiota from birth. For example,
breastfeeding seems to protect infants against the development of various diseases
and disorders. Breastfeeding is associated with reduced rates of acute infections in
infancy and decreased risk of obesity later in life. This protection may be partially
due to breast-milk itself, which contains immunologically active compounds, such
as antibacterial enzymes and antibodies against pathogens. The transfer of
maternal intestinal microbiota capable of educating the neonate’s immune system
also contributes to this protection. In addition, human breast milk contains
complex prebiotic polysaccharides that promote the colonization of the infant
gut and sustain the beneﬁcial microbial communities [16].
Another important factor represented by nutrition is that Lactobacillales and
Protobacterias growth is promoted by increased levels of amino acids and short-
chain carbohydrates in the intestine that they can metabolize [9]. It is reported that
oxygen levels exert strong inﬂuence on the bacterial composition, and that high
level of oxygen allows for the ﬁrst colonization of the gut by facultative anaerobic
bacteria, such as enterococci, enterobacteria, and staphylococci, and aerobic
bacteria. At later stages, microbe-derived metabolites and the reduction of oxygen
levels caused by the presence of these bacteria make the environment more
favorable for the growth of obligate anaerobic bacteria, such as Bacteroides,
Clostridia, and Biﬁdobacterium. The gut microbiota composition of a child after
the age of about 2 years resembles that of an adult [9]. As previously mentioned,
the colon colonization involves largely Firmicutes and Bacteroidetes, and their
growth is favored by their ability to metabolize complex or resistant carbohydrates
[9]. It has been shown that the diet has such a strong effect on the microbiota that
the modiﬁcation of ﬁber content can affect its composition in less than 24 h [9].
For example, an elevated content of ﬁber was associated with the presence of
Bacteroides, showing us that the gut microbiota evolves based on changes in the
diet composition [9].
Similar to the animal models, human intestinal integrity appears to be
compromised upon gliadin exposure, and due to the association between T1D and
celiac disease, it can be proposed that these diseases share speciﬁc risk factors, such
as gliadin, as demonstrated in Figure 4 [11]. Samples of human intestine exposed to
gliadin in vitro showed an ampliﬁed release of zonulin and increased permeability
[11]. The role of gliadin in the pathogenesis of T1D likely extends beyond intestinal
integrity, and the small intestine biopsies of T1D patients exposed to gliadin
exhibited an unusually high inﬂammatory response [11]. Production of cytokines
TNF-α and IL-8, both involved in the pathogenesis of T1D, is also stimulated by
gliadin, distinctively, in subjects with celiac disease [11].
Additionally, islet autoimmunity appears to increase in individuals who are
exposed to gliadin-containing foods prior to 6 months of age [11].
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Viral Infections
Viruses have, for a long time, been widely suspected as the environmental
trigger of T1D and are prime candidates since they are capable of activating both the
innate and adaptive immune systems. Their ability to induce strong immune
responses and causing inﬂammation in target organs also make them ideal candi-
dates for the initiation of islet autoimmunity. Certain viruses have been linked to
T1D, based on epidemiology, serology, histology, and rodent studies; however,
viruses have also been shown to prevent autoimmunity, as previously described in
the “hygiene hypothesis,” illustrating the potential complexity of the disease.
Epidemiological evidence
Infections with different viruses, such as Epstein–Barr virus, cytomegalovirus,
rotavirus, rubella virus, mumps virus, and others [17], have been associated with the
development of T1D; however, the strongest evidence in support of viral involve-
ment exists from the human enterovirus (HEV) [17–21]. Some of the isolated forms
of pancreatic HEV can induce T1D in mice [17] and are also able to infect and
destroy human islet cells in vitro [17]. The RNA of Coxsackievirus B (CVB) has
been detected in the blood of recent onset T1D patients [22], and the presence of
HEV RNA in the serum constitutes a risk factor for autoimmunity and T1D [23].
Other studies have been able to detect HEV proteins in the Langerhans islets of T1D
Figure 4. General schema outlining the possible relationships between gut microbiota/integrity and
development of type 1 diabetes in genetically predisposed individuals
432 JAKOBSEN AND SZEREDAY
Acta Microbiologica et Immunologica Hungarica 65, 2018
patients [24] and in the DAISY study, it was shown that the progression to T1D was
increased in children in the span of time following an enteroviral infection
characterized by the presence of viral RNA in blood [25, 26]. In addition, a
meta-analytic study demonstrated the odds ratio of 3.7 between HEV infection and
T1D-related autoimmunity, and 9.8 between HEV infection and clinical T1D,
showing a signiﬁcant association between HEV infection and T1D [27].
A particularly interesting study, notably the DiViD study, was the ﬁrst to
examine fresh pancreatic tissue at the diagnosis of T1D, for the presence of
viruses. Minimal pancreatic tail resection was performed for 3–9 weeks following
T1D onset in six adults while non-diabetic organ donors served as controls.
Enteroviral capsid protein 1 (VP1) was detected in the islets of all the T1D patients
and in two of the nine controls. Hyperexpression of class I HLA molecules was
found in the islets of all the patients, and in one of the nine controls, whereas
enterovirus-speciﬁc RNA sequences were detected in four of six patients, and in
none of the controls [28]. This is consistent with the possibility in which
enteroviral infection in the pancreatic islets contributes to disease progression in
humans.
Animal models
After inoculating 4-week-old NOD mice with CVB, it was shown that the
mice were well protected from developing T1D, but when older NOD mice were
used, CVB rapidly induced T1D onset [18]. It was shown that the age of the
mouse, correlating to the extent of the islet inﬂammation, was the key component
in this difference, and the virus was only demonstrable in the islets of older mice.
As the NOD mice aged and the insulitis increased, the mice became more
susceptible and less protected from the onset of T1D, and this change in status,
from a defensive posture to T1D, to increased induction occurred as a function of
the extent of the hosts own autoimmune island inﬂammation. The strain of the
virus used to inoculate the mice was also important, illustrating an increase in the
rapidly replicating CVB strain, and required fewer infectious particles to induce
T1D, than a slower replication strain [29], showing that the virus strain and
infectious dose were, as many other infectious agents, linked. These observations
have lead to the proposed relationship between HEV infection and T1D. A HEV
infection which meets the key criteria to trigger T1D in an at-risk individual might
also be understood as an example of another HEV infectious disease, much like a
poliovirus (PV) infection which induces polio. In reference to polio, less than 1%
of PV infections lead to paralytic disease; therefore, it can be reasonably assumed
that similar infection ratios hold true for other HEV [29].
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Discussion
One of the popular theories relating to the environmental triggers of T1D is
the hygiene hypothesis, which states that the increased frequency of T1D in
several countries can be explained by the decline of infections, generally, as a
result of better hygiene, health, and medical conditions [6].
The geographical data suggest an environmental factor, as reviewed in
Figure 1 and the geographical map of incidence rate for childhood T1D is the
mirror image of that for infectious disease distribution, as seen in Figure 2.
Although differences between small geographical areas have also been found, and
are difﬁcult to explain, however, may be attributed to other environmental triggers
or differences when considering the socioeconomic status [5].
Migration studies support this theory by demonstrating how families
who emigrate from countries with low T1D incidence to a high T1D incidence
country generally feature an increased frequency of the disease in its ﬁrst-
generation migrants and vice versa. It is difﬁcult to assert that the increase in
T1D is due to a loss of a protective factor present in their nation of origin, and
not due to the presence of an unfavorable factor in their new home [5, 6].
Animal models have shown that in both BB-rats and NOD-mice, the
incidence of the T1D and the rapidity of onset depended particularly on the
sanitary conditions, illustrating how poor conditions decreased the disease rate of
incidence, and vice versa [5, 6]. Although no human therapeutic trial can prove
that a deliberate suppression of infections can trigger a rise in T1D, other studies
have been useful. Helminthiases treatment demonstrated that a decrease of the
parasite was linked to an increase of atopic disease, and vaccination against
S. pneumonia had a similar result, indicating a decrease of infection can cause an
increase of a certain disease [5, 6].
Several mechanisms have been studied to understand how infections can
provide defense and protection against certain autoimmune and allergic diseases.
Although there are no deﬁnite answers yet, studies have shown that infections
occurring earlier in a person’s life generally yields in assuring an increase in
defense, and similar results were found in mice [6].
Distinctly, another theory is related to the gut microbiota. A study highlight-
ed the risk of T1D onset in childhood and found it is inexplicably higher in
children delivered by C-section [11], yet interestingly, the supportive reasoning for
the C-section was unknown; therefore, in theory, the method of delivery is largely
inﬂuential on the gut microbiome composition.
Several studies show a relationship between the intestinal ﬂora and autoim-
mune diseases, especially IBD [9, 11], suggesting that a similar relationship
between T1D and the gut microbiota is possible.
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Some of the more interesting results originating from animal studies
highlight how NOD mice, induced with B. cereus, chronic viral infections, and
mycobacterial infections or stimulus with bacterial antigens, decreased or delayed
the development of T1D [11] leading to the concept that a germ-free environment
and/or a restricted ﬂora increase the risk of T1D.
Human studies have began to emerge, implying the intestinal microbiota in
children who developed T1D, did indeed, have a higher proportion of Bacter-
oidetes phyla and lower proportion of Firmicutes phyla [11], but this was an
abbreviated study including eight case subjects and four controls. Similar to
animal models, human intestinal integrity seems to be compromised upon
gliadin exposure [11], and due to the association between T1D and celiac
disease, it can be postulated that these diseases share speciﬁc risk factors, as seen
in Figure 4.
A very interesting topic is how modulation or manipulation of the gut
microbiota can affect the disease. Most of the research today is from animals,
and some studies have shown the following interesting results: NOD mice that
consumed water lead to an increase in Bacteroidetes and a decrease in
Firmicutes [12]. This change in composition has been associated with an
increased onset of diabetes in NOD mice [12] and humans [11]. Also, when
transplanting gut microbiota from MyD88-deﬁcient NOD mice to NOD mice, a
delay of T1D was observed, and transferring male microbiota to female
microbiota in NOD mice also showed protection against the disease [12].
Additionally, the administration of the probiotic VSL#3 has shown to prevent
diabetes in NOD mice [12], while giving vancomycin was also able to inhibit
diabetes development by depleting many bacteria except for A. muciniphilia [8].
This creates a strong suspicion that modulating the ﬂora can be an important
therapeutic alternative, although a lot more research must be conducted in
relation to how these modulations affect the disease and the immune-mediated
mechanisms behind them.
The ﬁnal environmental trigger of T1D appropriately discussed in this
literature review highlights viral infections, speciﬁcally, the enterovirus. Several
studies from both humans and animals have been reported, and one of the more
striking reports originated from a human meta-analytic study shows an odds ratio
of 9.8 between HEV infections and clinical T1D [28]. Although there may be
some weaknesses to the meta-analytic observational study, a signiﬁcant hetero-
geneity to the different study designs and methods used should be mentioned.
Another interesting ﬁnding is, from the DiViD study, examining fresh pancreatic
tissue at the time of T1D diagnosis, ﬁnding VP1 and hyperexpression of class I
HLA in the islets of all the T1D patients, and enterovirus-speciﬁc RNA sequence
in four of six patients, with the results being conﬁrmed in various laboratories [18].
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This result does not prove the causality between HEV infection and T1D, although
it supports the view in which a low-grade enterovirus infection is present in the
pancreatic islets at the time of T1D diagnosis; however, when considering there
were only six patients and nine controls, similar studies should be accomplished to
conﬁrm this in a larger group of patients.
Conclusions
T1D is indeed a complex multifactorial disease, and evidence exists,
supporting all the aforementioned potential environmental triggers, although
none of them are deﬁnite or without shortcomings. In consideration of the
hygiene hypothesis and its focus on the lack of infectious agents, the gut
microbiota theory focuses on the composition of the intestinal ﬂora and the fact
that the enteroviruses transmit generally through the fecal-oral route and replicate
primarily in the gut offer us an indication of the close relationship between these
theories.
Instead of the disease trigger being one or the other, it can be proposed that
all of them, separately or in combination, are capable of triggering T1D in
genetically susceptible humans. Like many other diseases, possessing several
environmental risk factors, T1D may also be induced by several potential risk
factors. The lack of certain infections, the alteration of the gut microbiota, and
speciﬁc viral infections are all in close relationship and their common denominator
is their ability to alter the immune system.
In T1D, a cure for the disease today may seem far-fetched. It can be
postulated that any new treatment or cure focusing only on one of the aforemen-
tioned potential triggers can, at best, decrease the incidence rate. For example, a
vaccine against a virus triggering T1D still leaves the possibility of T1D as the
trigger mechanism from factors relating to the gut microbiota or the hygiene
hypothesis. Therefore, the key factor lies in understanding in far greater detail how
the different potential triggers affect our immune system and precisely, what path
the immune system takes leading to the destruction of β-cells. Only when the
immune mechanism is accurately mapped, can a complete cure be produced
focusing on the common immune pathway the different triggers affect.
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